Safety of ofloxacin (OFLX) and fosfomycin sodium (FOM) ear drops

International Journal of Pediatric Otorhinolaryngology

Volumn 71, Issue 6, 2007, Pages 979-983

  Yamano, T ^a   Morizono, T ^a   Shiraishi, K ^a   Miyagi, M ^a   Imamura, A ^a   Kato, T ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Ear drops; Fosfomycin sodium; Guinea pig; Ofloxacin; Ototoxicity

Indexed keywords

EAR DROPS; FOSFOMYCIN; FOSFOMYCIN SODIUM; OFLOXACIN; TARIBID OTIC SOLUTION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG SCREENING; GUINEA PIG; MIDDLE EAR; NONHUMAN; OTITIS; OTOTOXICITY; PRIORITY JOURNAL; SOUND TRANSMISSION; STIMULUS RESPONSE;

ACTION POTENTIALS; ANIMALS; ANTI-BACTERIAL AGENTS; AUDIOMETRY; AUDITORY THRESHOLD; DRUG EVALUATION, PRECLINICAL; EAR, MIDDLE; FOSFOMYCIN; GUINEA PIGS; OFLOXACIN; PHARMACEUTICAL SOLUTIONS; ROUND WINDOW; SAFETY; TIME FACTORS;

EID: 34247635032     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2007.03.014     Document Type: Article

References (14)

1. Nobori T., Hanamure Y., Matuzaki T., Miyazaki Y., Kouno M., Imamura Y., et al. A study of the influence of ofloxacin on the cochlea after topical administration into the middle ear cavity. Otologia Fukuoka 34 (1988) 1028-1034
2. Sato K., Miyazaki T., and Yamamoto Y. Experimental and pathological study of the safety of fosfomycin (FOM) otic solution on the cochlear organ. Otologia Fukuoka 31 (1985) 1237-1242
3. Morizono T., and Sikora M.A. The otototoxicity of topically applied Povidone-iodine preparations. Arch. Otolaryngol. 108 (1982) 210-213
4. Morizono T. Toxicity of ototopical drugs: animal modeling. Ann. Otol. Rhinol. Laryngol. 99 6 (1990) 42-45
5. Ikeda K., Morizono T., and Juhn S.K. Cochleotoxicity of otic drops in the chinchilla: comparative study of Bestron and Cortisporin. Am. J. Otolaryngol. 12 6 (1991) 429-434
6. T. Morizono, Ototopical agents: ototoxicity in animal studies, in: C.D. Bluestone, M.A. Kenna, (Eds.), Workshop on Chronic Suppurative Otitis Media: Etiology and Management, Ann. Otol. Rhinol. Laryngol. 97 (Suppl. 131) (1988) 28-30.
7. C.G. Wright, W.L. Meyerhoff, Ototopical agents: efficacy or toxicity in humans, in: C.D. Bluestone, M.A. Kenna, (Eds.), Workshop on Chronic Suppurative Otitis Media: Etiology and Management, Ann. Otol. Rhinol. Laryngol. 97 (Suppl. 131) (1988) 30-32.
8. Y. Nomura, Otological significance of the round window, in: C.R. Pfoltz (Ed.), Advances in Oto-Rhino-Laryngology, S karger, New York, vol. 33, 1984, pp. 1-162.
9. Ikeda K., Sakagami M., Morizono T., and Juhn S.K. The permeability of the round window membrane to middle-sized molecules in purulent otitis media. Arch. Otolaryngol. Head Neck Surg. 116 (1990) 57-60
10. Ikeda K., and Morizono T. Round window membrane permeability during experimental purulent otitis media: altered cortisporin ototoxicity. Ann. Otol. Rhinol. Laryngol. 99 (1990) 46-48
11. Sahni R.S., Paparella M.M., Schachern P.A., Goycoolea M.V., and Le C.T. Thickness of the human round window membrane in different forms of otitis media. Arch. Otolaryngol. Head Neck Surg. 113 (1987) 630-634
12. Kellerhals G. Horschaden durch ototoxische Ohrtropfen. HNO 26 (1978) 49-52
13. Podoshin L., Fradis M., and David J.B. Ototoxicity of ear drops in patients suffering from chronic otitis media. J. Laryngol. Otol. 103 (1989) 46-50
14. Lundy L.B., and Graham M.D. Ototoxicity and ototopical medications: a survey of otolaryngologists. Am. J. Otol. 14 (1993) 141-146